Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. Kamalian et al. conducted an in-depth [[proteomics]] of [[cerebrospinal fluid]] (CSF) in 28 shunt-responsive [[idiopathic normal pressure hydrocephalus]] patients, 38 Mild [[Cognitive Impairment]] (MCI) due to [[Alzheimer's disease]], and 49 healthy controls. Utilizing the Olink Explore 3072 panel, they identified distinct proteomic profiles in iNPH that highlight significant downregulation of synaptic markers and cell-cell adhesion proteins. Alongside [[vimentin]] and inflammatory markers upregulation, these results suggest [[ependyma]]l layer and transependymal flow dysfunction. Moreover, downregulation of multiple proteins associated with [[congenital hydrocephalus]] (e.g., [[L1CAM]], [[PCDH9]], [[ISLR2]], [[ADAMTSL2]], and [[B4GAT1]]) points to a possible shared molecular foundation between [[congenital hydrocephalus]] and iNPH. Through orthogonal partial least squares discriminant analysis (OPLS-DA), a panel comprising 13 proteins has been identified as potential diagnostic biomarkers of iNPH, pending external validation. These findings offer novel insights into the [[idiopathic normal pressure hydrocephalus pathophysiology]], with implications for improved [[idiopathic normal pressure hydrocephalus diagnosis]] ((Kamalian A, Shirzadeh Barough S, Ho SG, Albert M, Luciano MG, Yasar S, Moghekar A. Molecular [[signature]]s of normal pressure hydrocephalus: a large-scale proteomic analysis of cerebrospinal fluid. Fluids Barriers CNS. 2024 Aug 8;21(1):64. doi: 10.1186/s12987-024-00561-5. PMID: 39118132.)). b4gat1.txt Last modified: 2024/08/09 09:07by 127.0.0.1